SBIR resubmissions are still allowed, but success depends on correcting reviewer concerns, not simply revising language or adding more detail.


SBIR resubmissions are still allowed, but success depends on correcting reviewer concerns, not simply revising language or adding more detail.

NIH’s small business program is back, but expectations have shifted. Here is what innovators need to understand before stepping in.

NIH removed the April 5 SBIR/STTR deadline because no active funding announcements exist. Future opportunities will appear first on Grants.gov.